Transient induction of phenotypic resistance in human lymphoblastoid cells following sequential use of two antifolates.

M. Hamrell,J. Laszlo,W. D. Sedwick
1981-05-01
Molecular Pharmacology
Abstract:This paper demonstrates an unexpected antagonism of cytoxicity with the use of two antifolates. Cell killing depended on the order of administration, as sequential in vitro exposures, to a lipid-soluble antifolate, metoprine (DDMP), and methotrexate (MTX). This was manifested in greatly increased survival of cultures following a program of 4 days of exposure of human lymphoblastoid (WIL-2) cells to 5 µM DDMP, 2 days of recovery in medium without drug, then 4 days of exposure to either 5 µM DDMP or 1 µM MTX. By contrast, 1 µM MTX in the first cycle, regardless of the drug used in the second cycle, gave no survivors. Serial measurement of dihydrofolate reductase levels showed that DDMP led to increased levels of free dihydrofolate reductase during the recovery period which were not inhibited by a second exposure to drug. These results emphasize the importance of sequence and timing when drugs are used in multiagent protocols, even when the drugs have a common enzyme target.
What problem does this paper attempt to address?